2 September, 2020, by clincapture-client
ClinCapture is excited to announce Captivate® 3.4 with new features that improve your experience. We’ve enhanced the system and added additional tools.
Here is a breakdown of the changes:
Build
New VAS Scale
Printable annotated case report forms (CRFs)
Customizable date/time format
Ability for users to fully build and configure patient surveys themselves within ePRO
Live
Data import via CSV file
PHI settings based on roles
Query owner export
Improved email alert notifications
Calendar enhancements
Advanced Reporting
Report data by event or in aggregate
Added Log base 10 function
View and test reporting in the test environment
Additional features
Subject calendar visit windows
Automatic triggers to send ePRO surveys
To learn more about our latest features and enhancements, contact your Account Manager at ClinCapture .
Up Next
-
Read more +10 July, 2024
Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics
Liquid Biopsy: The Future of Non-Invasive Cancer Diagnostics Liquid biopsy is an innovative and increasingly influential method in cancer diagnostics, offering significant advantages over traditional tissue biopsy by detecting cancer information through a simple blood sample. This non-invasive technique allows for the detection of circulating tumor DNA (ctDNA), circulating tumo -
Read more +11 June, 2024
Genomics in Cancer Diagnosis and Prognosis and the Role of Electronic Data Capture (EDC) Systems
Genomics in Cancer Diagnosis and Prognosis and the Role of Electronic Data Capture (EDC) Systems The integration of genomics into the field of oncology has ushered in a transformative era in cancer care, enhancing both diagnosis and prognosis by allowing clinicians to understand the genetic basis of cancers more deeply. This shift towards a genomics-driven approach enables more -
Read more +29 May, 2024
Emerging Trends in Precision Medicine: Integrating Epigenetics into Oncology
Trends in Precision Medicine: Integrating Epigenetics into Oncology Precision medicine in oncology is continually evolving, with recent advances in epigenetics presenting new pathways for understanding and treating cancer more effectively. Epigenetics involves the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence — es